Erica L. Liebelt

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

UAMS

Also affiliated: Northwestern University (1999); Boston Children's Hospital (1993–1999); Geisinger Medical Center (1997–2003); Lurie Children's Hospital (1999); Seattle Children's Hospital (1999); Pennsylvania State University (1999–2000); Nationwide Children's Hospital (1999); United States Food and Drug Administration (2012); Yale New Haven Hospital (1996); Cardinal Glennon Children’s Medical Center (1999); Children's Mercy Hospital (1999); Harvard University (1992–1997); Johns Hopkins University (1998–2001); University of Massachusetts Chan Medical School (1998); University of Alabama (2003–2014); University of Washington (1999); Loma Linda University (2006); Brown University (2001); University of Arkansas Medical Center (2023); Johns Hopkins Medicine (1998–2001); Denver Health Medical Center (2006); Palmetto Health Richland (2006); Children's of Alabama (2018); University of Alabama at Birmingham (2003–2022); Yale University (1994–1999); Banner - University Medical Center Phoenix (2006); Washington Poison Center (2018–2021); Children's Hospital & Medical Center (1999); Johns Hopkins Hospital (2001); UAB Medicine (2003–2022); Saint Louis University (1999); Geisinger Health System (2000–2003); University of Missouri–Kansas City (1999)

28 h-index 79 pubs 2,317 cited

Research Areas

Biomedical Subjects

OverviewAI-generated summary

Erica L. Liebelt's research focuses on the toxicology of various substances and their impact on human health, particularly concerning exposures reported to poison control centers. Her work has investigated trends in overdose, abuse, and misuse of substances such as diphenhydramine and synthetic cannabinoids within the United States. Liebelt has also examined exposures related to kratom among older adults and suspected suicidal cannabis exposures.

Her publications include analyses of manufactured cannabis products and cannabis plant products, as well as a study on acute hypersensitivity reactions by antivenom type. Liebelt's scholarship metrics indicate a significant body of work, with an h-index of 28, 80 total publications, and 2,300 total citations. She has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Laura P. James and Jennifer L. Perry.

Liebelt's research interests align with understanding patterns of substance use and exposure, contributing to public health data and informing potential interventions. Her recent work extends to a 2025 publication analyzing snake bite registry data, demonstrating a broad scope within the field of toxicology and emergency medicine.

Metrics

h-index: 28
Publications: 79
Citations: 2,317

Selected Publications

Decontamination (2026)

DOI OpenAlex
Analysis of Acute Hypersensitivity Reactions by Antivenom Type and Geographic Location in the North American Snake Bite Registry (NASBR) (2025)

Journal of Medical Toxicology 9 citations DOI OpenAlex
Impact of the Coronavirus Disease 2019 Pandemic on Clinical Trends in Pediatric Intentional Self-Poisonings (2025)

Pediatric Emergency Care 1 citation DOI OpenAlex
Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations (2023)

Chemical Research in Toxicology 5 citations DOI OpenAlex
Suspected Suicidal Cannabis Exposures Reported to US Poison Centers, 2009-2021 (2023)

JAMA Network Open 11 citations DOI OpenAlex
Pharmacogenomic Profiling of Pediatric Patients on Psychotropic Medications in an Emergency Department (2022)

Pediatric Emergency Care 2 citations DOI OpenAlex
Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016–2019 (2022)

Clinical Toxicology 14 citations DOI OpenAlex
Methylene Blue (2021)

Pediatric Emergency Care 52 citations DOI OpenAlex
Kratom exposures among older adults reported to U.S. poison centers, 2014–2019 (2021)

Journal of the American Geriatrics Society 21 citations DOI OpenAlex
Trends and Characteristics of Manufactured Cannabis Product and Cannabis Plant Product Exposures Reported to US Poison Control Centers, 2017-2019 (2021)

JAMA Network Open 25 citations DOI OpenAlex